Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Glaysher

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
BMC Cancer|November 25, 2004
The in vitro effect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumoursLouise A Knight, Federica Di Nicolantonio, Pauline Whitehouse, et al.
BMC Cancer|January 30, 2009
Activity of mevalonate pathway inhibitors against breast and ovarian cancers in the ATP-based tumour chemosensitivity assayLouise A Knight, Christian M Kurbacher, Sharon Glaysher, et al.
Anti-Cancer Drugs|August 31, 2006
Effect of culture conditions on the chemosensitivity of ovarian cancer cell linesAugusta Fernando, Sharon Glaysher, Mark Conroy, et al.
Journal of Breath Research|December 19, 2025
A Feasibility study using the ETL CoronaCheck® device to Identify iNciDent cases of SARS-CoV-2: FIND SARS-CoV-2Lauren Fox, Sharon Glaysher, Milan Chauhan, et al.
Anti-Cancer Drugs|September 8, 2011
The effect of tricyclic antidepressants on cutaneous melanoma cell lines and primary cell culturesKatharine A Parker, Sharon Glaysher, Jeremy Hurren, et al.
Journal of Clinical Pathology|October 7, 2010
The molecular basis of the chemosensitivity of metastatic cutaneous melanoma to chemotherapyKatharine A Parker, Sharon Glaysher, Marta Polak, et al.
Anti-Cancer Drugs|July 11, 2003
Heterogeneity of chemosensitivity of esophageal and gastric carcinomaStuart J Mercer, Shaw S Somers, Louise A Knight, et al.
JMIR Research Protocols|May 21, 2017
The SENSOR Study: Protocol for a Mixed-Methods Study of Self-Management Checks to Predict Exacerbations of Pseudomonas Aeruginosa in Patients with Long-Term Respiratory ConditionsClaire Roberts, Thomas L Jones, Samal Gunatilake, et al.
Anti-Cancer Drugs|August 19, 2006
The effect of imatinib mesylate (Glivec) on human tumor-derived cellsLouise A Knight, Federica Di Nicolantonio, Pauline A Whitehouse, et al.
BMJ Open Respiratory Research|January 8, 2021
Predicting survival in malignant pleural mesothelioma using routine clinical and laboratory characteristicsSamal Gunatilake, David Lodge, Daniel Neville, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
BMC Cancer|November 25, 2004
The in vitro effect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumoursLouise A Knight, Federica Di Nicolantonio, Pauline Whitehouse, et al.
BMC Cancer|January 30, 2009
Activity of mevalonate pathway inhibitors against breast and ovarian cancers in the ATP-based tumour chemosensitivity assayLouise A Knight, Christian M Kurbacher, Sharon Glaysher, et al.
Anti-Cancer Drugs|August 31, 2006
Effect of culture conditions on the chemosensitivity of ovarian cancer cell linesAugusta Fernando, Sharon Glaysher, Mark Conroy, et al.
Journal of Breath Research|December 19, 2025
A Feasibility study using the ETL CoronaCheck® device to Identify iNciDent cases of SARS-CoV-2: FIND SARS-CoV-2Lauren Fox, Sharon Glaysher, Milan Chauhan, et al.
Anti-Cancer Drugs|September 8, 2011
The effect of tricyclic antidepressants on cutaneous melanoma cell lines and primary cell culturesKatharine A Parker, Sharon Glaysher, Jeremy Hurren, et al.
Journal of Clinical Pathology|October 7, 2010
The molecular basis of the chemosensitivity of metastatic cutaneous melanoma to chemotherapyKatharine A Parker, Sharon Glaysher, Marta Polak, et al.
Anti-Cancer Drugs|July 11, 2003
Heterogeneity of chemosensitivity of esophageal and gastric carcinomaStuart J Mercer, Shaw S Somers, Louise A Knight, et al.
JMIR Research Protocols|May 21, 2017
The SENSOR Study: Protocol for a Mixed-Methods Study of Self-Management Checks to Predict Exacerbations of Pseudomonas Aeruginosa in Patients with Long-Term Respiratory ConditionsClaire Roberts, Thomas L Jones, Samal Gunatilake, et al.
Anti-Cancer Drugs|August 19, 2006
The effect of imatinib mesylate (Glivec) on human tumor-derived cellsLouise A Knight, Federica Di Nicolantonio, Pauline A Whitehouse, et al.
BMJ Open Respiratory Research|January 8, 2021
Predicting survival in malignant pleural mesothelioma using routine clinical and laboratory characteristicsSamal Gunatilake, David Lodge, Daniel Neville, et al.
Pageof 3